Degarelix Prescribing at MOWBRAY HOUSE SURGERY
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
103
Total Quantity
103
NHS Cost
£11.0K
vs National Avg
+493.5%
MOWBRAY HOUSE SURGERY prescribed 103 items of Degarelix over the last 12 months at a cost of £11,047 to the NHS. This is 493.5% above the national average prescribing rate. Degarelix is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
6
Jul 2026
9
Jul 2026
10
Jul 2026
1
Jul 2026
18
Jul 2026
6
Jul 2026
9
Jul 2026
7
Jul 2026
8
Jul 2026
9
Jul 2026
10
Jul 2026
10
Prescribing Details
| Total Items | 103 |
|---|---|
| Total Quantity | 103 |
| Total NHS Cost | £11,047 |
| Presentations | 1 different forms |
| vs National Average | +493.5% |
Degarelix Prescribing Comparison
| This practice | 103 items |
|---|---|
| National average per practice | 17 items |
| Difference | +493.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.